Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Torrent Pharmaceuticals will attend an Investors' Meet at Emkay - Confluence 2026 in Mumbai on August 14, 2026. The event will involve both group and one-on-one sessions with company representatives.
Torrent Pharma received an independent ESG Rating of 70 from NSE Sustainability Ratings & Analytics. This reflects its Environmental, Social, and Governance performance.
A transcript of the conference call with analysts and investors regarding the financial results for the quarter ended June 30, 2026, has been made available on the company's website.